Gilco, a prescription lab in England, has shut down after its managing director had to put it into administration, a form of bankruptcy protection. Keith Stevens, the managing director, tried to sell the business, but the buyer balked over issues in the agreement. The company's banks became impatient, and the ...
Buying a membership today will give you:
To continue reading this article register now.